The Medicines Control
Authority of Zimbabwe (MCAZ) is looking to allow hemp-based CBD products to be
given as medicine to patients.
The MCAZ posted a letter to Twitter July 26 informing all licensed cannabis/hemp producers,
manufacturers, importers/exporters and retail pharmacists that the organization
is now accepting and reviewing applications for the approval of selling
hemp-based CBD products as complementary medicines to patients, under certain
conditions, Bloomberg reported.
Some conditions include
submitting product samples and a certificate of analysis, stating the
indications, warning and contraindications, and more.
The MCAZ stated at the end of
the letter, “Any hemp-based CBD product applications that do not meet the
criteria above may not be approved for distribution and will be confiscated.
Further, sellers may be prosecuted for selling unapproved complementary